| scholarly article | Q13442814 |
| editorial | Q871232 |
| P2093 | author name string | Nanduri R Prabhakar | |
| P2860 | cites work | Effect of episodic hypoxia on sympathetic activity and blood pressure | Q33866568 |
| Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients | Q34122262 | ||
| Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study | Q34508280 | ||
| Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. | Q36243544 | ||
| Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study | Q48704784 | ||
| Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. | Q48708402 | ||
| New mechanisms for the cardiovascular effects of sleep apnea | Q48710566 | ||
| Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy | Q48716348 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 859-860 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Sleep apneas: an oxidative stress? | |
| P478 | volume | 165 |
| Q36952103 | Atrial fibrillation in obstructive sleep apnea |
| Q36482623 | Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more |
| Q48602980 | Cerebrovascular inflammation after brief episodic hypoxia: modulation by neuronal and endothelial nitric oxide synthase |
| Q44641932 | Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure |
| Q38080761 | Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome |
| Q37863567 | Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea |
| Q35681074 | Established vascular effects of continuous positive airway pressure therapy in patients with obstructive sleep apnoea-an update |
| Q30419870 | Etiopathogenetic mechanisms of pulmonary hypertension in sleep-related breathing disorders |
| Q36268676 | Heart failure and sleep apnoea: to sleep perchance to dream. |
| Q34927284 | High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study |
| Q35151688 | Indications for treatment of obstructive sleep apnea in adults |
| Q41134375 | Intrarenal hemodynamic and oxidative stress in patients with obstructive sleep apnea syndrome |
| Q46067976 | Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept |
| Q48129666 | Mandibular advancement device and CPAP upon cardiovascular parameters in OSA. |
| Q35335969 | Mechanisms and clinical consequences of untreated central sleep apnea in heart failure |
| Q37145667 | Mechanisms of endothelial dysfunction in obstructive sleep apnea |
| Q33499690 | Modulating temporal and spatial oxygenation over adherent cellular cultures |
| Q38058356 | Morbidities associated with obstructive sleep apnea |
| Q35806577 | Nonapnea Sleep Disorders in Patients Younger than 65 Years Are Significantly Associated with CKD: A Nationwide Population-Based Study. |
| Q37086887 | Obstructive sleep apnea syndrome and asthma: what are the links? |
| Q35104040 | Obstructive sleep apnea, inflammation, and the metabolic syndrome |
| Q36015440 | Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases |
| Q35621286 | Oxidative stress as a therapeutic target in diabetes: revisiting the controversy |
| Q46654980 | Oxidative stress in obstructive sleep apnoea |
| Q35155800 | Periodic breathing and genetics |
| Q28206353 | Post-transcriptional control of human maxiK potassium channel activity and acute oxygen sensitivity by chronic hypoxia |
| Q85072622 | Reactive oxygen species are the cause of the enhanced cardiorespiratory response induced by intermittent hypoxia in conscious rats |
| Q51690158 | Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. |
| Q48375473 | Reactive oxygen species mediate central cardiorespiratory network responses to acute intermittent hypoxia |
| Q48103325 | Risk factors for, and prevalence of, sleep apnoea in cardiac rehabilitation facilities in Germany: The Reha-Sleep registry |
| Q30455065 | Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method |
| Q50221289 | Serum level of vascular endothelial growth factor in patients with obstructive sleep apnea hypopnea syndrome |
| Q35043788 | Should a pharmaceutical be approved for the broad indication of excessive sleepiness? |
| Q37332753 | Sleep duration and disorders in pregnancy: implications for glucose metabolism and pregnancy outcomes |
| Q36736012 | Sleep-disordered breathing and oxidative stress in preclinical chronic mountain sickness (excessive erythrocytosis) |
| Q35055444 | Sleep-disordered breathing, control of breathing, respiratory muscles, and pulmonary function testing in AJRCCM 2002. |
| Q45918482 | Superoxide scavengers improve rat pharyngeal dilator muscle performance. |
| Q48301152 | The association of oxidative stress with central obesity in obstructive sleep apnea |
| Q35995471 | The effect of acute intermittent hypercapnic hypoxia treatment on IL-6, TNF-alpha, and CRP levels in piglets. |
| Q84578365 | [Obstructive sleep apnoea and cardiovascular disease--a retrospective study] |
| Q80393843 | [Oxidative stress and sleep apnea-hypopnea syndrome] |
Search more.